VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 210 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,283,193 | +330.3% | 136,947 | +968.6% | 0.01% | +350.0% |
| Q1 2023 | $298,205 | -39.4% | 12,815 | -34.1% | 0.00% | -33.3% |
| Q4 2022 | $492,457 | -75.8% | 19,457 | -81.6% | 0.00% | -72.7% |
| Q3 2022 | $2,034,000 | -51.9% | 105,507 | -36.4% | 0.01% | -57.7% |
| Q2 2022 | $4,227,000 | +2.4% | 165,941 | +3.4% | 0.03% | -25.7% |
| Q1 2022 | $4,128,000 | +8.5% | 160,503 | +76.6% | 0.04% | -2.8% |
| Q4 2021 | $3,806,000 | +1392.5% | 90,899 | +1450.1% | 0.04% | +1100.0% |
| Q3 2021 | $255,000 | -83.0% | 5,864 | -81.5% | 0.00% | -82.4% |
| Q2 2021 | $1,499,000 | +81.7% | 31,706 | +96.9% | 0.02% | +54.5% |
| Q1 2021 | $825,000 | – | 16,101 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |